Your browser doesn't support javascript.
loading
The effect of the European traditional use directive on the register of herbal medicinal products in Spain.
Tejedor-García, Noelia; García-Pastor, Coral; Navalmoral-Arenas, Estefanía; Blas-Espada, Javier; Madrigal-Martínez, Antonio; de Lucio-Cazaña, Francisco Javier.
Afiliação
  • Tejedor-García N; Departamento de Biología de Sistemas, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain. Electronic address: ntejedor@hotmail.com.
  • García-Pastor C; Departamento de Biología de Sistemas, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
  • Navalmoral-Arenas E; Departamento de Biología de Sistemas, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
  • Blas-Espada J; Departamento de Biología de Sistemas, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
  • Madrigal-Martínez A; Departamento de Biología de Sistemas, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
  • de Lucio-Cazaña FJ; Departamento de Biología de Sistemas, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
Gac Sanit ; 29(3): 221-3, 2015.
Article em En | MEDLINE | ID: mdl-25835515
BACKGROUND: Directive 2004/24/EC, which came into force in 2011, created new regulatory requirements for traditional herbal medicines (THM). This study compared the Spanish THM registry before and after the Directive came fully into force in 2011. METHODS: We consulted the herbal medicinal plant and drug catalogues (General Council of the Official Colleges of Pharmacists), the website of the European Medicines Agency (EMA), and retail web sites. RESULTS: Of 315 THM (from 39 companies) licensed in Spain in 2010, only 48 (10 companies) remained licensed in 2013, mainly due to their withdrawal: the EMA had received just 123 applications from Spain and at least 34% formerly licensed THM had shifted to the less strictly regulated food sector, while up to 54% might have disappeared from the market. However, there is still a significant presence of retail websites making illegal health claims. CONCLUSION: In Spain, the public health benefits of the Directive 2004/24/EC might be less than expected.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicina Herbária Tipo de estudo: Prognostic_studies País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicina Herbária Tipo de estudo: Prognostic_studies País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article